Oncology & Cancer

FDA approves expanded indication for Jaypirca

The U.S. Food and Drug Administration has approved an expanded indication for Eli Lilly's Jaypirca (pirtobrutinib), the first and only noncovalent Bruton tyrosine kinase (BTK) inhibitor for adults with relapsed or refractory ...

Alzheimer's disease & dementia

Engineers decode dementia type using AI and EEG brainwave analysis

Dementia is a group of disorders that gradually impair memory, thinking and daily functioning. Alzheimer's disease (AD), the most common form of dementia, affects about 7.2 million Americans aged 65 and older in 2025. Frontotemporal ...

page 4 from 11